Back Brown, JC (1982) Gastric Inhibitory Polypeptide
Biologics, including recombinant protein- or peptide-based drugs, offer targeted treatment options for various complex and non-genetic diseases
In contrast, those treated with GLP-1 RAs showed significant reductions in the risks of mortality, MACEs, and MAKEs during a median follow-up period of 2.3 years
Responses were sorted based on inquiry type, and were then analyzed to determine the most important findings of the study.
This hormone plays a key role in managing blood sugar and appetite by: Slowing digestion Reducing hunger signals Helping regulate glucose levels When GLP-1 agonists are used consistently, they can help reduce appetite, improve portion control, and support steady weight loss
Back Labhart, A (1978) 'Intuition, luck and misfortune in diabetes research', Diabetologia , 14, 353-58